Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 577 results from 1 sources
http://web.expasy.org/cellosaurus/CVCL_2477

Cite this Ximbio Cat# 152454, RRID:CVCL_2477
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment:

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_1570

Cite this ATCC Cat# CCL-249, RRID:CVCL_1570
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Omics: Transcriptome analysis. Discontinued: ATCC; CCL-249.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_4438

Cite this RRID:CVCL_4438
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: From: Ludwig Institute for Cancer Research, Melbourne branch; Melbourne; Australia. Doubling time: >4 days (PubMed=142798). Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0166 but was never distributed.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_4V91

Cite this RRID:CVCL_4V91
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Selected for resistance to: ChEBI; CHEBI:90227; Selumetinib (AZD6244).

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_EG21

Cite this RRID:CVCL_EG21
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Microsatellite instability: Stable (MSS) (PubMed=26894854). Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from metastatic site: Liver.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this KCB Cat# KCB 200710YJ, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this IZSLER Cat# BS TCL 87, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this NCBI_Iran Cat# C139, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this ICLC Cat# HTL97023, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this CLS Cat# 300137/p1665_CaCo-2, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this KCLB Cat# 30037.1, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this ECACC Cat# 86010202, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this RCB Cat# RCB0988, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this BCRJ Cat# 0059, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this DSMZ Cat# ACC-169, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this ATCC Cat# HTB-37, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0025

Cite this ECACC Cat# 09042001, RRID:CVCL_0025
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Doubling time: ~80 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053). Sequence variation: APC p.Gln1367Ter (PubMed=24755471). Sequence variation: SMAD4 p.Asp351His (PubMed=24755471). Sequence variation: TP53 p.Glu204Ter (PubMed=16418264; PubMed=24755471). Omics: Deep antibody staining analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: miRNA expression profiling. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0233

Cite this RRID:CVCL_0233
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment:

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0306

Cite this RRID:CVCL_0306
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Sequence variation: CTNNB1 p.Ser45Phe (from parent cell line). Sequence variation: KRAS p.Gly12Asp (from parent cell line). Sequence variation: PIK3CA p.His1047Arg (from parent cell line).

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0218

Cite this KCB Cat# KCB 200719YJ, RRID:CVCL_0218
Organism: Homo sapiens
Disease: Colon adenocarcinoma
Category: Cancer cell line
Comment: Part of: AstraZeneca Colorectal cell line (AZCL) panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 25 hours (PubMed=25984343); 23.8 hours (NCI-DTP). Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger). Sequence variation: Homozygous for APC p.Thr1556fs*3 (PubMed=17088437; PubMed=24755471). Sequence variation: Heterozygous for BRAF p.Val600Glu (PubMed=17088437; PubMed=24755471). Sequence variation: Homozygous for TP53 p.Tyr103fs*37 (PubMed=17088437). Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep proteome analysis. Omics: Deep quantitative phosphoproteome analysis. Omics: Deep quantitative proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from metastatic site: Ascites.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X